Hong Kong · SFC › Firms
SHENZHEN HEPALINK PHARMACEUTICAL GROUP CO., LTD.
深圳市海普瑞藥業集團股份有限公司
Hong Kong listed company Stock code 9989
Board members with SFC licence histories
Back to top ↑| Name | Position | From | To |
|---|---|---|---|
| Sun, Xuan孫暄 | Vice Chairman · Executive | 1 Feb 2020 | 6 May 2021 |
Listings
Back to top ↑| Market | Stock code | First traded | Delisted |
|---|---|---|---|
| SEHK Main Board | 9989 | 8 Jul 2020 | — |
Former names
Back to top ↑- 深圳市海普瑞藥業股份有限公司 · until Feb 2017
- Shenzhen Hepalink Pharmaceutical Co., Ltd · until Feb 2017
- 深圳市海普瑞藥業有限公司 · until Dec 2007
- Shenzhen Hepalink Pharmaceutical Company Limited · until Dec 2007
- Shenzhen Hepalink Biotechnology Company Limited · until Sep 2002
- 深圳市海普瑞生物技術有限公司 · until Sep 2002
- 深圳市海普瑞實業發展有限公司 · until Jan 2001
- Shenzhen Hepalink Industrial Development Company Limited · until Jan 2001
Sources: Webb-site archive (Enigma database). Status checked with: SFC monthly report; SFC register snapshot; Webb-site archive (Enigma database). As of: 31 Oct 2026.
History comes from the Webb-site archive and is updated from public data. It may lag the official register, so check the SFC for the current position. Report an error.